The Fair Trading Commission (“FTC”) has issued a Statement of Non‑Objection regarding the proposed acquisition of Massy Distribution (Jamaica) Limited (“MDJL”) by Acado Limited (“Acado”).
The FTC assessed the transaction pursuant to Section 17 of the Fair Competition Act (FCA), which prohibits agreements that have the purpose, effect, or likely effect of substantially lessening competition in a market. The findings of this assessment are presented in the FTC’s Report dated February 12, 2026.
The Report identifies several competition concerns arising from the transaction, particularly in relation to the sale of insulin products in Jamaica. To address these concerns, the FTC has recommended a series of ameliorative measures, which it considers sufficient to prevent any likely anti‑competitive effects. These measures are as follows:
- Discontinuation of Distribution: Both Acado and its distributor, Aventa Jamaica Ltd. (“Aventa”), will discontinue the distribution of the Eli Lilly brand of insulin medication once distribution commences by a new distributor. This is expected to occur by September 2026.
- Maintenance of Viability: Acado and Aventa will maintain the full economic viability, marketability, and competitiveness of the Eli Lilly insulin business until the new distributor assumes distribution responsibilities.
- Consistency of Supply and Service: Acado and Aventa will ensure a consistent supply of Eli Lilly insulin products, maintaining sales and mark‑up levels, quality standards, service levels, and customer support, until the new distributor takes over distribution.
- Compliance Reporting: Acado will appoint an independent party to submit monthly Compliance Reports to the FTC on Aventa’s sales and mark‑up levels until the new distributor assumes distribution.
- No Affiliation with New Distributor: Acado and Aventa will not be affiliated in any way with the new distributor. Neither entity may be involved with the new distributor, including but not limited to exercising decisive influence over its management, operations, or strategic direction; soliciting or inducing its employees or customers; or acquiring or seeking to acquire any of its assets.
Pursuant to Section 5 of the FCA, and in accordance with the requirements for Consent Orders, the FTC has entered into a Consent Agreement with Acado and Aventa under Regulation 6(3) of the Fair Competition (Notices and Procedures) Regulations. The Consent Agreement constitutes a comprehensive remedy designed to address and prevent the likely anti‑competitive harm identified in the FTC’s assessment.